| scholarly article | Q13442814 |
| P2093 | author name string | D Kabat | |
| E J Platt | |||
| S E Kuhmann | |||
| S L Kozak | |||
| P2860 | cites work | Roles of CD4 and coreceptors in binding, endocytosis, and proteolysis of gp120 envelope glycoproteins derived from human immunodeficiency virus type 1 | Q22003751 |
| HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor | Q22242268 | ||
| Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity | Q36873079 | ||
| The adsorption of coliphage lambda to its host: Effect of variations in the surface density of receptor and in phage-receptor affinity | Q38359591 | ||
| Morphogenesis and morphology of HIV. Structure-function relations | Q38677045 | ||
| HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor | Q38908745 | ||
| Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity | Q38911711 | ||
| Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry | Q38977702 | ||
| A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5 | Q39000358 | ||
| Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors | Q39110633 | ||
| Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. | Q39355095 | ||
| Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity | Q39413074 | ||
| A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1. | Q39460971 | ||
| CCR5-Mediated human immunodeficiency virus entry depends on an amino-terminal gp120-binding site and on the conformational integrity of all four extracellular domains | Q39549575 | ||
| Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1. | Q39579651 | ||
| CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. | Q39605077 | ||
| Exceptional fusogenicity of Chinese hamster ovary cells with murine retroviruses suggests roles for cellular factor(s) and receptor clusters in the membrane fusion process | Q39874520 | ||
| Minimal aggregate size and minimal fusion unit for the first fusion pore of influenza hemagglutinin-mediated membrane fusion | Q40156309 | ||
| Critical role of enhanced CD4 affinity in laboratory adaptation of human immunodeficiency virus type 1. | Q40870962 | ||
| Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function | Q40964911 | ||
| CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. | Q41151327 | ||
| Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines | Q41157521 | ||
| Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus | Q41611077 | ||
| Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry | Q43694761 | ||
| HIV requires multiple gp120 molecules for CD4-mediated infection | Q44171806 | ||
| Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines | Q46722581 | ||
| Chemokine receptors: keys to AIDS pathogenesis? | Q47964346 | ||
| The organization of the envelope projections on the surface of HIV | Q53043052 | ||
| Role of CD4 and CCR5 Levels in the Susceptibility of Primary Macrophages to Infection by CCR5-Dependent HIV Type 1 Isolates | Q59661561 | ||
| Identification of a major co-receptor for primary isolates of HIV-1 | Q22251282 | ||
| Physics of chemoreception | Q24546294 | ||
| Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody | Q27759364 | ||
| A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors | Q28118386 | ||
| HIV entry and its inhibition | Q28273919 | ||
| The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates | Q28282895 | ||
| CCR5 HIV-1 coreceptor activity. Role of cooperativity between residues in N-terminal extracellular and intracellular domains | Q28646662 | ||
| CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1 | Q28646859 | ||
| A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding | Q28646883 | ||
| Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene | Q29614892 | ||
| Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection | Q29614956 | ||
| HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 | Q29616094 | ||
| Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. | Q29622903 | ||
| Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers | Q30442203 | ||
| Overcoming interference to retroviral superinfection results in amplified expression and transmission of cloned genes | Q33634507 | ||
| Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry? | Q33645423 | ||
| Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5 | Q33647608 | ||
| CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection | Q33782193 | ||
| Multiple residues contribute to the inability of murine CCR-5 to function as a coreceptor for macrophage-tropic human immunodeficiency virus type 1 isolates | Q33782312 | ||
| Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans | Q33782608 | ||
| Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1 | Q33784182 | ||
| In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. | Q34445208 | ||
| Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. | Q34448190 | ||
| Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1. | Q35833860 | ||
| CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. | Q35876191 | ||
| Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses | Q35898770 | ||
| Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events | Q36237488 | ||
| Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages | Q36340560 | ||
| Change in coreceptor use correlates with disease progression in HIV-1--infected individuals | Q36376800 | ||
| CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro | Q36377185 | ||
| Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding | Q36380755 | ||
| Constitutive cell surface association between CD4 and CCR5. | Q36397946 | ||
| Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. | Q36632478 | ||
| Dissociation of HIV-1 from follicular dendritic cells during HAART: mathematical analysis | Q36773750 | ||
| P433 | issue | 15 | |
| P921 | main subject | cooperation | Q380962 |
| P304 | page(s) | 7005-7015 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1 | |
| P478 | volume | 74 |
| Q39152233 | "Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches. |
| Q35263959 | A biosensor assay for studying ligand-membrane receptor interactions: binding of antibodies and HIV-1 Env to chemokine receptors |
| Q28475890 | Accelerated immunodeficiency by anti-CCR5 treatment in HIV infection |
| Q34610959 | Adaptive mutations in a human immunodeficiency virus type 1 envelope protein with a truncated V3 loop restore function by improving interactions with CD4. |
| Q33870292 | Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region |
| Q40563193 | Adsorption and infectivity of human immunodeficiency virus type 1 are modified by the fluidity of the plasma membrane for multiple-site binding |
| Q28485983 | Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity |
| Q39682931 | Altering expression levels of human immunodeficiency virus type 1 gp120-gp41 affects efficiency but not kinetics of cell-cell fusion |
| Q41996301 | An allosteric rheostat in HIV-1 gp120 reduces CCR5 stoichiometry required for membrane fusion and overcomes diverse entry limitations |
| Q44058307 | An anti-CCR5 monoclonal antibody and small molecule CCR5 antagonists synergize by inhibiting different stages of human immunodeficiency virus type 1 entry |
| Q34187261 | Analysis of the functional relationship between V3 loop and gp120 context with regard to human immunodeficiency virus coreceptor usage using naturally selected sequences and different viral backbones. |
| Q33845055 | Antigenically distinct conformations of CXCR4. |
| Q34574462 | Attachment and Fusion Inhibitors Potently Prevent Dendritic Cell-Driven HIV Infection |
| Q38934421 | Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist Maraviroc. |
| Q39240591 | Bioinformatic analysis of neurotropic HIV envelope sequences identifies polymorphisms in the gp120 bridging sheet that increase macrophage-tropism through enhanced interactions with CCR5. |
| Q36370878 | Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains |
| Q34574397 | CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells |
| Q38329768 | CCR5 promoter haplotype transcription complex characterization |
| Q39605953 | CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells |
| Q41860559 | CCR5Delta32 protein expression and stability are critical for resistance to human immunodeficiency virus type 1 in vivo |
| Q39015489 | CD4 and CCR5 constitutively interact at the plasma membrane of living cells: a confocal fluorescence resonance energy transfer-based approach |
| Q40081130 | CD4 interacts constitutively with multiple CCR5 at the plasma membrane of living cells. A fluorescence recovery after photobleaching at variable radii approach. |
| Q33848876 | CD4-independent use of Rhesus CCR5 by human immunodeficiency virus Type 2 implicates an electrostatic interaction between the CCR5 N terminus and the gp120 C4 domain |
| Q37839350 | Cell entry of enveloped viruses. |
| Q36296739 | Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligands |
| Q35985849 | Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote. |
| Q39886418 | Characterization of HIV-2 chimeric viruses unable to use CCR5 and CXCR4 coreceptors |
| Q29619744 | Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus |
| Q36184275 | Chemokine receptor internalization and intracellular trafficking |
| Q37348882 | Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm |
| Q37834097 | Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies |
| Q35947621 | Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switching |
| Q35825546 | Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: functional complementation of specific defects in gp120 and gp41. |
| Q34999203 | Coreceptor usage and biological phenotypes of HIV-1 isolates |
| Q44480307 | DC-SIGN and DC-SIGNR: helping hands for HIV. |
| Q33840771 | DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus |
| Q24601035 | DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans |
| Q34139616 | Dancing to the tune of chemokines |
| Q57079961 | Dendrimers as topical microbicides with activity against HIV |
| Q39149893 | Determinant for the inhibition of ecotropic murine leukemia virus infection by N-linked glycosylation of the rat receptor |
| Q34875765 | Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entry |
| Q29617562 | Distribution and three-dimensional structure of AIDS virus envelope spikes |
| Q43066917 | Double-edged genetic swords and immunity: lesson from CCR5 and beyond |
| Q40800273 | Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes |
| Q33504556 | Early steps of HIV-1 fusion define the sensitivity to inhibitory peptides that block 6-helix bundle formation |
| Q40468565 | Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells. |
| Q30499561 | Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions |
| Q33283730 | Electron tomography of the contact between T cells and SIV/HIV-1: implications for viral entry. |
| Q36237524 | Emerging drug targets for antiretroviral therapy |
| Q44399525 | Entry Inhibitors SCH-C, RANTES, and T-20 Block HIV Type 1 Replication in Multiple Cell Types |
| Q39454698 | Env-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitors |
| Q41979690 | Ephrin-B2 expression critically influences Nipah virus infection independent of its cytoplasmic tail |
| Q28478341 | Estimating the threshold surface density of Gp120-CCR5 complexes necessary for HIV-1 envelope-mediated cell-cell fusion |
| Q40219338 | Feline leukemia virus T entry is dependent on both expression levels and specific interactions between cofactor and receptor |
| Q33854213 | Frequent substitution polymorphisms in African green monkey CCR5 cluster at critical sites for infections by simian immunodeficiency virus SIVagm, implying ancient virus-host coevolution |
| Q40127843 | Functional links between the fusion peptide-proximal polar segment and membrane-proximal region of human immunodeficiency virus gp41 in distinct phases of membrane fusion |
| Q36891039 | G541R within the 4070A TM Protein Regulates Fusion in Murine Leukemia Viruses |
| Q24338224 | Gelsolin activity controls efficient early HIV-1 infection |
| Q28188558 | HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors |
| Q37945205 | HIV-1 Entry, Inhibitors, and Resistance |
| Q22242967 | HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse |
| Q35665842 | HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug |
| Q28344746 | HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use |
| Q40563186 | Heterogeneity of envelope molecules shown by different sensitivities to anti-V3 neutralizing antibody and CXCR4 antagonist regulates the formation of multiple-site binding of HIV-1. |
| Q91945548 | How virus size and attachment parameters affect the temperature sensitivity of virus binding to host cells: Predictions of a thermodynamic model for arboviruses and HIV |
| Q37102101 | Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment. |
| Q40133069 | Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts |
| Q39683422 | Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells |
| Q34234127 | Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors |
| Q34465007 | Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins |
| Q34800822 | Increasing hydrophobicity of residues in an anti-HIV-1 Env peptide synergistically improves potency |
| Q39870010 | Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities |
| Q35709090 | Inhibiting sexual transmission of HIV-1 infection |
| Q36631937 | Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets |
| Q33707328 | Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus |
| Q40292970 | Linkage of reduced receptor affinity and superinfection to pathogenesis of TR1.3 murine leukemia virus |
| Q34859370 | Localization of CD4 and CCR5 in living cells |
| Q39521282 | Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion. |
| Q41752911 | Mathematical model of multivalent virus-antibody complex formation in humans following acute and chronic HIV infections |
| Q39106404 | Maturation of the viral core enhances the fusion of HIV-1 particles with primary human T cells and monocyte-derived macrophages |
| Q30448451 | Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor |
| Q37263225 | Mechanisms of receptor/coreceptor-mediated entry of enveloped viruses |
| Q38246407 | Membrane organization of virus and target cell plays a role in HIV entry. |
| Q39755287 | Mobility of the human immunodeficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: implications for HIV fusion and entry events |
| Q41967451 | Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody |
| Q21559473 | Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop |
| Q40505451 | Multiple residues in the extracellular domains of CCR3 are critical for coreceptor activity |
| Q46040511 | Multistage adsorption of diffusing macromolecules and viruses |
| Q33846366 | Mutations within the putative membrane-spanning domain of the simian immunodeficiency virus transmembrane glycoprotein define the minimal requirements for fusion, incorporation, and infectivity |
| Q34187142 | Oligomeric beta-structure of the membrane-bound HIV-1 fusion peptide formed from soluble monomers |
| Q40544036 | Optimisation of the degree of sulfation of a polymer based construct to block the entry of HIV-1 into cells |
| Q27321418 | P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions |
| Q37104590 | Pannexin1 hemichannels are critical for HIV infection of human primary CD4+ T lymphocytes |
| Q24673772 | Pit2 assemblies at the cell surface are modulated by extracellular inorganic phosphate concentration |
| Q36195192 | Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus |
| Q93115348 | Predominance of the heterozygous CCR5 delta-24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface |
| Q35020532 | Progressive truncations C terminal to the membrane-spanning domain of simian immunodeficiency virus Env reduce fusogenicity and increase concentration dependence of Env for fusion |
| Q39785030 | Quantifying the relationship between HIV-1 susceptibility to CCR5 antagonists and virus affinity for antagonist-occupied co-receptor |
| Q39118166 | Raft localization of CXCR4 is primarily required for X4-tropic human immunodeficiency virus type 1 infection |
| Q33676520 | Rapid dissociation of HIV-1 from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high level of infectivity of virions |
| Q35146136 | Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors |
| Q34010373 | Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. |
| Q39069264 | Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1. |
| Q37121416 | Recruitment of HIV-1 envelope occurs subsequent to lipid mixing: a fluorescence microscopic evidence |
| Q37068522 | Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1. |
| Q36944098 | Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity |
| Q28237665 | Regulation of the immune response by the interaction of chemokines and proteases |
| Q57372060 | Rescue of HIV-1 Receptor Function through Cooperation between Different Forms of the CCR5 Chemokine Receptor |
| Q37185404 | Resistance to human immunodeficiency virus type 1 (HIV-1) generated by lentivirus vector-mediated delivery of the CCR5{Delta}32 gene despite detectable expression of the HIV-1 co-receptors |
| Q39056684 | Restriction of multiple divergent retroviruses by Lv1 and Ref1 |
| Q37713831 | Reversible and efficient activation of HIV-1 cell entry by a tyrosine-sulfated peptide dissects endocytic entry and inhibitor mechanisms |
| Q40471343 | Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef |
| Q24608200 | Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells |
| Q34348930 | Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization |
| Q30865013 | Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells |
| Q34330529 | Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus |
| Q34415921 | Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics |
| Q36078450 | Short Communication: HIV-1 Variants That Use Mouse CCR5 Reveal Critical Interactions of gp120's V3 Crown with CCR5 Extracellular Loop 1 |
| Q34354324 | Similar regulation of cell surface human T-cell leukemia virus type 1 (HTLV-1) surface binding proteins in cells highly and poorly transduced by HTLV-1-pseudotyped virions |
| Q42283259 | Simulations reveal that the HIV-1 gp120-CD4 complex dissociates via complex pathways and is a potential target of the polyamidoamine (PAMAM) dendrimer |
| Q35906141 | Stochastic entry of enveloped viruses: fusion versus endocytosis |
| Q90438646 | Stoichiometric Analyses of Soluble CD4 to Native-like HIV-1 Envelope by Single-Molecule Fluorescence Spectroscopy |
| Q42177914 | Stoichiometric parameters of HIV-1 entry |
| Q33737656 | Stoichiometry of antibody neutralization of human immunodeficiency virus type 1. |
| Q30447936 | Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1 |
| Q38050485 | Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA. |
| Q37902736 | Structure and working of viral fusion machinery |
| Q39161979 | Synergistic inhibition of R5 HIV-1 by maraviroc and CCR5 antibody HGS004 in primary cells: implications for treatment and prevention |
| Q33846502 | Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry. |
| Q40384583 | Ternary complex formation of human immunodeficiency virus type 1 Env, CD4, and chemokine receptor captured as an intermediate of membrane fusion |
| Q28188544 | The HIV Env-mediated fusion reaction |
| Q37131419 | The origins of diversity and specificity in g protein-coupled receptor signaling |
| Q41345703 | The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment |
| Q34695601 | The temperature arrested intermediate of virus-cell fusion is a functional step in HIV infection |
| Q36156531 | The trinity of the cortical actin in the initiation of HIV-1 infection |
| Q35741691 | The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages |
| Q34148120 | Time-resolved imaging of HIV-1 Env-mediated lipid and content mixing between a single virion and cell membrane |
| Q91912876 | Towards a thermodynamic mechanistic model for the effect of temperature on arthropod vector competence for transmission of arboviruses |
| Q36607127 | Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5. |
| Q39031676 | Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome |
| Q33707333 | Variants of human immunodeficiency virus type 1 that efficiently use CCR5 lacking the tyrosine-sulfated amino terminus have adaptive mutations in gp120, including loss of a functional N-glycan |
| Q37941707 | Viral infection: Moving through complex and dynamic cell-membrane structures. |
| Q30493649 | Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibition |
| Q91909222 | [CCR5 antagonists and HIV-1 infection: Bases and consequences of this therapeutic approach] |
Search more.